Kubo, Yoshikazu <br/><br/>
Urocortin prevents indomethacin-induced small intestinal lesions in rats through activation of CRF2 receptors.  [electronic resource] 

 -  Digestive diseases and sciences  Jun 2010 
 - 1570-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-2568 
<br/><br/><label>Standard No.: </label>10.1007/s10620-009-0930-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aniline Compounds--administration & dosage<br/>Animals<br/>Bacterial Translocation--drug effects<br/>Corticotropin-Releasing Hormone--administration & dosage<br/>Cytoprotection<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Gastrointestinal Agents--administration & dosage<br/>Gastrointestinal Motility--drug effects<br/>Indomethacin<br/>Injections, Intravenous<br/>Intestine, Small--drug effects<br/>Male<br/>Nitric Oxide Synthase Type II--genetics<br/>Peptic Ulcer--chemically induced<br/>Peptide Fragments--administration & dosage<br/>Peptides, Cyclic--administration & dosage<br/>Peroxidase--metabolism<br/>Pyrimidines--administration & dosage<br/>RNA, Messenger--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Corticotropin-Releasing Hormone--agonists<br/>Time Factors<br/>Urocortins--administration & dosage<br/>CRF Receptor, Type 1